Glenn Lesser MD, FACP - Practical Recommendations in Immuno and Molecular Oncology (PRIMO)

Glenn Lesser MD, FACP

When:
November 2, 2022 @ 10:54 pm – 11:54 pm
2022-11-02T22:54:00-01:00
2022-11-02T23:54:00-01:00
Contact:
Lesser

Glenn J. Lesser, MD, FACP
Louise McMichael Miracle Professor in Oncology
Associate Chief, Section on Hematology and Oncology
Principal Investigator, Wake Forest NCORP Research Base
Co-Leader, Neuro-Oncology Research Program,
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, NC

Glenn Lesser MD, FACP, is the inaugural Louise McMichael Miracle Professor and Associate Chief in the section on Hematology and Oncology in the Department of Internal Medicine at the Atrium Health Wake Forest Baptist Medical Center, with joint appointments in the Departments of Anesthesiology, Neurosurgery and Public Health Sciences. He completed his undergraduate education at Duke University, received his MD from the Penn State Hershey College of Medicine and finished his Internal Medicine residency at Wake Forest in 1991. He completed a Fellowship in Medical Oncology at the Johns Hopkins Oncology Center in 1994 and returned to Wake Forest as the Director of Medical Neuro-Oncology in 1995. Dr. Lesser is the Co-Program leader of the Neuro-Oncology Research Program of the Atrium Health Wake Forest Baptist Comprehensive Cancer Center and the contact MPI of the Wake Forest NCORP Research Base since its inception in 2014. He is also the recently re-elected co-chair of the NCI Symptom Management and Quality of Life Steering Committee.  Lesser has extensive clinical trial expertise including serving as the PI, institutional PI or research team member for well over 130 neuro-oncology and symptom science studies. He is the Neuro-Oncology section editor of Current Treatment Options in Oncology and a member of the editorial board of Neuro-Oncology Practice. His clinical and research interests include the development of novel therapeutic agents to treat adult malignant brain tumors and symptom management issues experienced by patients with cancer.

 

Leave a Reply

Your email address will not be published. Required fields are marked *